How many Science and Technology Clusters took part in the fourth All S&T Clusters Meet?

The correct answer is the Principal Scientific Adviser to the Government of India. Prof. Ajay Kumar Sood, who holds that post, chaired the meet on 9 and 10 October 2026 at Panjab University in Chandigarh, and the Office of the Principal Scientific Adviser runs the whole clusters programme. He was joined by Scientific Secretary Parvinder Maini and Vishal Choudhary, Scientist-F in his office. Option A is wrong because the Union Minister of Science and Technology was not named as the chair of this meeting. Option C is wrong although the Director of IIT Ropar did attend, as a participant rather than as the chair; the same is true of the Director of IIT Jodhpur. Option D is wrong for the same reason: the Vice-Chancellor of Panjab University took part because the host campus was hers, not because she presided. Only option B is correct.

The correct answer is the Prime Minister's Science, Technology and Innovation Advisory Council, known by the short form PM-STIAC. The clusters programme of the Office of the Principal Scientific Adviser was conceived in 2020 after that council recommended it, and it brings academia, research institutions, industry, startups and government together to tackle regional challenges through science, technology and innovation. Option A is wrong because NITI Aayog, the government's policy think tank, was not credited with the recommendation. Option C is wrong as the University Grants Commission deals with higher education standards and funding rather than with innovation clusters of this kind. Option D is wrong because the Council of Scientific and Industrial Research runs its own chain of national laboratories and is not the body whose advice created the programme. Only option B is correct.

The correct answer is 2047. The Minister asked industry to accelerate innovation and scale up technological capability so that India meets the national objectives set for 2047 and strengthens its strategic sovereignty, a year that marks a century of independence. Option A, 2030, is wrong in this context because that year is attached to a different goal in the same speech, the bioeconomy target of US$300 billion, and mixing the two is the commonest error here. Options B and C name years that do not appear in the address. The Minister also linked the 2047 goal to practical conditions: indigenous technology, dependable energy supply, private participation in research under the Research, Development and Innovation initiative, and partnerships among government, industry, academia and start-ups that can scale a successful innovation quickly.

The correct answer is the PHD Chamber of Commerce and Industry. The Minister spoke at the 121st Annual Session of PHDCCI in New Delhi, where industry leaders, entrepreneurs and other stakeholders had gathered to discuss growth and innovation priorities. He said such chambers can act as the bridge between researchers and businesses, facilitating investment and helping an innovation travel from the laboratory to a prototype and then to a market-ready product. Options A, C and D name FICCI, CII and ASSOCHAM, which are also major Indian industry associations, but the address in question was delivered at the PHDCCI session and the edition number, the 121st, belongs to that body. Remember the edition along with the name, since paper setters often ask for the number of the session rather than only the host organisation.

The correct answer is US$300 billion. The bioeconomy has grown from roughly US$10 billion in 2014 to about US$196 billion, crossing the US$195 billion mark, and the ambition stated is to take it to US$300 billion by 2030. Option B, US$196 billion, is the present size rather than the target, and is therefore the most tempting wrong answer: a candidate who remembers only one figure will often pick the one just read. Option A understates the current size, so it cannot be a forward target. Option D names a round number that has not been set for this decade. The Minister tied the growth to an expanding biotechnology start-up ecosystem, presenting life sciences and advanced research as a source of new enterprises, domestic capability and economic value rather than only of published papers.